Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Specimen Handling 613pembrolizumab 568Magnetic Resonance Spectroscopy 538Carboplatin 429Cyclophosphamide 381Cisplatin 374Biopsy 355Paclitaxel 312Nivolumab 307Gemcitabine 302Radiotherapy 260Bevacizumab 237Dexamethasone 213fludarabine 207Docetaxel 189durvalumab 181atezolizumab 175Oxaliplatin 171Rituximab 167Fluorouracil 167venetoclax 166Pemetrexed 164Doxorubicin 161Capecitabine 158Radiation 157Radiosurgery 147Etoposide 138Leucovorin 134Ipilimumab 134Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × small molecule inhibitor THX-B × 90 days × Clear all
NCT05694715 2026-03-17

Combination Therapy in Cancers With Mutations in DNA Repair Genes

University of California, San Francisco

Phase 1 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡